Latest Breaking News On - Paula soteropoulos - Page 1 : comparemela.com

uniQure (QURE) Announces Resignation of Paula Soteropoulos from Board

uniQure (QURE) Announces Resignation of Paula Soteropoulos from Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Paula soteropoulos

Charles Alex | Obituary | Salem News

Charles Alex passed away. This is the full obituary where you can share condolences and memories. Published in the Salem News on 2023-10-11.

North readingUnited statesCedar grove cemeteryWest peabodyPaula soteropoulosAlexia soteropoulosPolytimi alexopoulosAnna zaimesPanagiota tsoutsanisCharlesd alexNicholaos alexopoulosMarian alexCharlie alexDimitri pissiosJames alexIoanna tsipianitopoulou

FY2024 EPS Estimates for uniQure Raised by Analyst (NASDAQ:QURE)

uniQure (NASDAQ:QURE – Get Rating) – HC Wainwright increased their FY2024 earnings estimates for shares of uniQure in a report released on Thursday, December 15th. HC Wainwright analyst P. Trucchio now expects that the biotechnology company will post earnings of ($1.20) per share for the year, up from their previous estimate of ($1.49). The consensus […]

Alexander edward kutaPaula soteropoulosWilliam blairCantor fitzgeraldQure company profileGoldman sachs groupEnvestnet asset management incSwiss national bankMeeder asset management incVictory capital management incGet ratingQure stockDirector paula soteropoulosAsset managementCapital managementNational bank

Dianthus Therapeutics Launches with $100M to Develop Selective Antibody Complement Therapeutics to Treat Severe and Rare Autoimmune Diseases

/PRNewswire/ Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today announced.

Evan thompsonSimrat randhawaRivka gluckMarino garciaTellus bioventuresTomas kiselakPaula soteropoulosRobert mcgarrEdward carrKristina maximenkoBusiness development at zealand pharmaProgram alliance managementFidelity management research companyAffairs at aurinia pharmaceuticalsChief executive officerLonnie moulder

5AM Ventures Closes $750 Million Across Two Life Science

SAN FRANCISCO and BOSTON, April 04, 2022 (GLOBE NEWSWIRE) 5AM Venture Management, LLC (“5AM”) is pleased to announce the closing of two new funds,.

United statesSan franciscoRebecca luciaAndrew schwabKush parmarSanofi genzymePaula soteropoulosTranscelerate biopharmaHead of specialty development at bristol myers squibbVenture managementTufts department of chemicalGlobal development at amgenKyowa kirin incManaging partnerElliott levyVenture partner